Skip to main content
Equibles

ARGX · Argenx SE · Metrics

Track ARGX — free

Use ARGX with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research ARGX.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$958.91 -11.75 (-1.21%) At close · Sep 30
Rebalance outlook locked
Market Cap
$60.40B
Shares
62.56M
Volume · Sep 30 243.93K Avg daily vol (3M) 285.26K

ARGX metrics

49 of 115 screener metrics currently available.

Open in screener

Market overview

2 metrics
Share price
$970.66
Market cap
$60.40B

Price action

20 metrics
Price change (1W)
+0.7%
Price change (30D)
-5.9%
Price change (3M)
+4.6%
Price change (6M)
+32.9%
Price change (YTD)
+15.4%
Price change (1Y)
+35.0%
Trailing year
Price change (5Y)
+229.0%
52-week high
$1,058.90
52-week low
$663.93
Change from 52-week high
-8.3%
Change from 52-week low
+46.2%
Annualized volatility
34.8%
Annualized volatility (3M)
45.8%
Beta
0.3
RSI (14D)
48.0
Price vs SMA 50
+1.8%
Price vs SMA 200
+14.2%
Avg volume (3M)
285,257
Relative volume
1.1
Average dollar volume
$267.81M

Company

3 metrics
Sector
Healthcare
Industry
Biotechnology
Shares outstanding
62.56M

Valuation

12 metrics
P / E (TTM)
—
Trailing earnings
PEG ratio
—
EV / revenue
—
EV / EBITDA
—
EV / EBIT
—
P / sales
—
P / book
8.2
reciprocal yield 12.1%
FCF yield
—
TTM · current market cap
Buyback yield
—
P / FCF
—
P / operating cash flow
—
Earnings yield
—

Historical valuation

8 metrics
P / E historical average (3Y)
—
P / E historical average (5Y)
—
EV / revenue historical average (3Y)
—
EV / revenue historical average (5Y)
—
EV / EBIT historical average (3Y)
—
EV / EBIT historical average (5Y)
—
EV / EBITDA historical average (3Y)
—
EV / EBITDA historical average (5Y)
—

Dividends & buybacks

7 metrics
Dividend yield
—
Trailing 12 months
Payout ratio
—
Shareholder yield
—
Dividend / share (TTM)
—
Dividend growth YoY
—
Dividend growth streak
—
Last ex-dividend
—

Earnings calendar

2 metrics
Next earnings
—
Last earnings
2025-12-31

Profitability

9 metrics
Gross margin
89.4%
Operating margin
24.8%
Trailing 12 months
Net margin
30.4%
Gross profit (TTM)
—
Operating profit (TTM)
—
Net income (TTM)
—
Trailing 12 months
Diluted EPS (TTM)
—
FCF margin
—
Effective tax rate
—

Per share

11 metrics
Revenue per diluted share (TTM)
—
Gross profit per diluted share (TTM)
—
Operating profit per diluted share (TTM)
—
EBITDA per diluted share (TTM)
—
Net income per diluted share (TTM)
—
Operating cash flow per diluted share (TTM)
—
Free cash flow per diluted share (TTM)
—
Capital expenditures per diluted share (TTM)
—
R&D per diluted share (TTM)
—
Stock compensation per diluted share (TTM)
—
Book value per share
$118.34

Growth

11 metrics
Revenue growth YoY
+88.6%
Year over year
Net income growth YoY
+55.1%
Revenue (TTM)
—
Trailing 12 months
EPS growth YoY
+53.1%
Shares change YoY
+1.8%
Year over year · more shares
Revenue CAGR (3Y)
+112.1%
Revenue CAGR (5Y)
+130.8%
EPS CAGR (3Y)
—
EPS CAGR (5Y)
—
FCF CAGR (3Y)
—
FCF CAGR (5Y)
—

Quality

14 metrics
Return on equity
17.6%
Return on assets
14.9%
Debt / equity
—
Current ratio
5.2
EBITDA (TTM)
—
Free cash flow (TTM)
—
Quick ratio
4.9
Interest coverage
—
Net debt / EBITDA
—
Return on invested capital
—
Trailing 12 months
Net cash
—
Latest balance sheet
Cash & equivalents
$3.49B
Total assets
$8.68B
Total debt
—

Cash flow & spend

7 metrics
Operating cash flow (TTM)
—
Capital expenditures (TTM)
—
R&D (TTM)
—
SG&A (TTM)
—
Stock compensation (TTM)
—
R&D / revenue
—
Stock compensation / revenue
—

Ownership (13F)

3 metrics
13F filers
511
13F filer change QoQ
+32
Institutional ownership
45.7%

Short interest

3 metrics
Short interest
2.1%
Latest settlement · 6.3 days to cover
Days to cover
6.3d
Short-squeeze score
58 / 100

Insider activity

2 metrics
Net insider buying (90D)
—
Insider-sentiment score
—

Risk flags

1 metrics
Going concern
—
Key facts CIK 1697862 CUSIP 04016X101 13F (30d) 11 filings 11 filers Visit website Investor relations